Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Post by wildbird1on Jul 08, 2021 11:28am
281 Views
Post# 33512101

Trust the numbers...

Trust the numbers...In Q1,2021 on $19 million revenues, the increase in cash in the Bank was +$2.6 million(over year end 2020).

Logic would have it that if Q2 tests revenue are less than Q1 tests revenue($19 million), the increase in cash in the Bank would have been less than the Q1 +$2.6 million increase.

On the contrary according to M.Gunter cash in the Bank has increased to $13 million, an increase of +$8.4 million.
An increase of 200% in cash in the Bank over Q1,2021 can't happen if revenues did not increase big time.

We are definitively missing some numbers.

My guess....
The press release do not mention Datametrex New Rapid Antigen tests revenues(only PCR tests are mentioned).
In the Deep Dive video(April 6,2021), M.Gunter said" We have already brought in several purchase orders on these Rapid Antigen Tests.

Trust the numbers...
Cash in the Bank can't increase by 200%($4.6 to $13 million) if revenue did not increase.






<< Previous
Bullboard Posts
Next >>